In 2000, the Weinberg Clinical Research Unit at National Jewish Health was created through the generosity of Harry & Jeanette Weinberg of Baltimore, Maryland. Our state-of-the-art pulmonary research facility allows Medical Director, Dr. Rohit Katial, fellow principal investigators and study staff to conduct clinical trials resulting in new disease prevention strategies, enhanced treatments and cures for asthma, allergies, COPD, emphysema, cystic fibrosis, HIV, interstitial lung disease (ILD), cardiology and immunotherapy. Please contact a Patient Recruiter at 303.398.1911 for more detailed information.
Asthma with or without Allergies: Do you have uncontrolled asthma despite using inhaled steroids daily? Researchers at National Jewish Health are conducting a clinical trial involving an investigational medication for asthma. If you are 18+ and have asthma with or without allergies, we may have a study for you! Study drug or placebo and study testing at no charge. Financial compensation provided to qualified participants. Please call a patient recruiter at 303.398.1911 to find out more. Learn more about how to participate in this study.
Child Asthma: Does your child have uncontrolled asthma? Researchers at National Jewish Health are studying an experimental add-on study drug for adolescents. Your child may qualify if they are between 12 – 17 years of age and their symptoms remain uncontrolled despite the daily use of inhaled corticosteroids and a second controller. Qualified study participants will receive investigational medication or placebo, asthma tests, ECG and financial compensation for their time and travel. Please call a patient recruiter at 303.398.1911 to find out more.
Learn more about how to participate in this study.
Smokers or Former Smokers: For those at risk for lung cancer, this lung cancer screening study includes at least one CT scan and a blood test. Learn more about how to participate in this study.
Moderate to Severe Symptomatic Asthma: Have you required additional treatment for your asthma in the past year? We are looking at the safety of two already FDA-approved asthma medications over 26 weeks for the treatment of uncontrolled asthma symptoms. Learn more about how to participate in this study.
Uncontrolled Asthma: A 43-week study looking at an investigational monoclonal antibody and its effect on adult asthma. Learn more about how to participate in this study.